California Cryobank:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:California Cryobank - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10520
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, CCB family services, report pregnancy, sibling registry, directed donor, family-cord, semen, embryo, egg storage, andrology and international shipping services. Its genetic services include donor profile extension, specialty testing and medical issue management services. CCB also offers an online search engine that helps to browse sperm donor catalog by any combination of height, weight, ethnicity, eye or hair color, education, blood type, or even religion from the privacy of one’s own home. The center has its presence in Los Angeles, Los Altos, Cambridge, New York and Houston. CCB is headquartered in Los Angeles, California, the US.

California Cryobank – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
California Cryobank, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
California Cryobank, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
California Cryobank, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
California Cryobank, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
California Cryobank, Medical Devices Deals, 2012 to YTD 2018 9
California Cryobank, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
California Cryobank, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
GI Partners Acquires California Cryobank from Longitude Capital and NovaQuest Capital 11
Longitude Venture and NovaQuest Pharma Acquire California Cryobank 13
Acquisition 14
California Cryobank Stem Cell Services Acquires Southern Cord 14
California Cryobank Stem Cell Services Acquires LifeLine Cryogenics 15
California Cryobank – Key Competitors 16
California Cryobank – Key Employees 17
California Cryobank – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Other Significant Developments 19
Oct 24, 2017: California Cryobank Introduces the Industry’s Most Thoroughly Screened Sperm Donors Through Their DNA Advantage Program 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
California Cryobank, Pharmaceuticals & Healthcare, Key Facts 2
California Cryobank, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
California Cryobank, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
California Cryobank, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
California Cryobank, Deals By Therapy Area, 2012 to YTD 2018 8
California Cryobank, Medical Devices Deals, 2012 to YTD 2018 9
California Cryobank, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GI Partners Acquires California Cryobank from Longitude Capital and NovaQuest Capital 11
Longitude Venture and NovaQuest Pharma Acquire California Cryobank 13
California Cryobank Stem Cell Services Acquires Southern Cord 14
California Cryobank Stem Cell Services Acquires LifeLine Cryogenics 15
California Cryobank, Key Competitors 16
California Cryobank, Key Employees 17
California Cryobank, Other Locations 18
California Cryobank, Subsidiaries 18

List of Figures
California Cryobank, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
California Cryobank, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
California Cryobank, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
California Cryobank, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
California Cryobank, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
California Cryobank, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
California Cryobank, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
California Cryobank, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
California Cryobank, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[California Cryobank:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • AMVIG Holdings Ltd.:企業の戦略・SWOT・財務情報
    AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Solaria Energia y Medio Ambiente S.A. (SLR):企業の財務・戦略的SWOT分析
    Solaria Energia y Medio Ambiente S.A. (SLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Globin Solutions Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globin Solutions Inc (Globin) is a pre-clinical stage biotechnology company with focus on the research and development of antidotal medicines for human poisoning. Its lead compound, Ngb H64Q, an antidote, a mutant version of the protein neuroglobin, has been found to scavenge carbon monoxide …
  • M3, Inc. (2413):企業の財務・戦略的SWOT分析
    M3, Inc. (2413) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Petro Matad Ltd (MATD):石油・ガス:M&Aディール及び事業提携情報
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Koki Holdings Co Ltd:企業の戦略的SWOT分析
    Koki Holdings Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Alamo Group, Inc.:戦略・SWOT・企業財務分析
    Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • pSivida Corp (PSDV)-医療機器分野:企業M&A・提携分析
    Summary pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug …
  • MILEI GmbH:企業の戦略・SWOT・財務情報
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Infinity Pharmaceuticals Inc (INFI)-製薬・医療分野:企業M&A・提携分析
    Summary Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company, which discovers and develops medicines to people suffering with difficult-to-treat diseases. It focuses on small molecule drugs designed to address diseases in the areas of cancer and inflammation. The co …
  • Newcastle Building Society:企業の戦略・SWOT・財務情報
    Newcastle Building Society - Strategy, SWOT and Corporate Finance Report Summary Newcastle Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • LSIS Co Ltd (010120):企業の財務・戦略的SWOT分析
    LSIS Co Ltd (010120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Proteome Sciences Plc (PRM):企業の製品パイプライン分析
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery, quality management and provision of data insights. The compan …
  • Euromoney Institutional Investor PLC:企業の戦略・SWOT・財務分析
    Euromoney Institutional Investor PLC - Strategy, SWOT and Corporate Finance Report Summary Euromoney Institutional Investor PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Kerr Corp:企業の戦略的SWOT分析
    Kerr Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Pan Malaysia Holdings Berhad:企業の戦略・SWOT・財務分析
    Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Old Mutual Plc:企業のM&A・事業提携・投資動向
    Old Mutual Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Old Mutual Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆